Cargando…
Allogeneic BMT in ATL: whom to transplant and which modality to use
Autor principal: | Kannagi, Mari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044933/ http://dx.doi.org/10.1186/1742-4690-11-S1-O32 |
Ejemplares similares
-
Augmentation of donor-derived Tax-specific CTL responses by a novel Tax epitope-specific CD4+ helper T-cells in ATL patients after allogeneic hematopoietic stem cell transplantation
por: Hasegawa, Atsuhiko, et al.
Publicado: (2014) -
Prospective studies of allogeneic hema topoietic stem cell transplantation for adult T-cell leukemia-lymphoma
por: Cho, Ilseung, et al.
Publicado: (2015) -
Can we cure ATL: new drugs and targeting ATL stem cells
por: Hermine, Olivier
Publicado: (2014) -
The phase-I study of a therapeutic vaccine to ATL patients with autologous dendritic cells pulsed with peptides corresponding to Tax-specific CTL epitopes
por: Suehiro, Youko, et al.
Publicado: (2014) -
Tax as a therapeutic target in ATL
por: Dassouki, Zeina, et al.
Publicado: (2015)